9 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Nuevolution Competitors or Alternatives

Nuevolution's top competitors include Bavarian Nordic, Symphogen and Genmab.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Nuevolution's company profile

Alex Haahr Gouliaev

Co-Founder & CEO

79/100
25 - 100
$28.9M
$25M - 100M
  • $28.9M
    $25M - 100M
  • 25 - 100
    $28.9M
  • $25M - 100M
  • 79/100
  • 25 - 100
  • $28.9M
  • $25M - 100M
View ProfileView
1
Nuevolution's Competitor - Bavarian Nordic logo

Paul Chaplin

President & CEO

90/100
1,609
$279.4M
$906.1M
  • $279.4M
    $906.1M
  • 1,609
    $279.4M
  • $906.1M
  • 90/100
  • 1,609
  • $279.4M
  • $906.1M
View ProfileView
2
Nuevolution's Competitor - Symphogen logo

Christophe Thurieau

CEO

90/100
100 - 250
$76.6M
$25M - 100M
  • $76.6M
    $25M - 100M
  • 100 - 250
    $76.6M
  • $25M - 100M
  • 90/100
  • 100 - 250
  • $76.6M
  • $25M - 100M
View ProfileView
3
Nuevolution's Competitor - Genmab logo

Jan van de Winkel

President & CEO

82/100
2,535
$639.9M
$3.1B
  • $639.9M
    $3.1B
  • 2,535
    $639.9M
  • $3.1B
  • 82/100
  • 2,535
  • $639.9M
  • $3.1B
View ProfileView
4
Nuevolution's Competitor - IOmet Pharma logo

Alan Wise

CEO

68/100
100 - 250
$12.2M
$100K - 5M
  • $12.2M
    $100K - 5M
  • 100 - 250
    $12.2M
  • $100K - 5M
  • 68/100
  • 100 - 250
  • $12.2M
  • $100K - 5M
View ProfileView
5
Nuevolution's Competitor - Juno Therapeutics logo

CEO

- -
1,000 - 5,000
$1.5B
$100M - 500M
  • $1.5B
    $100M - 500M
  • 1,000 - 5,000
    $1.5B
  • $100M - 500M
  • - -
  • 1,000 - 5,000
  • $1.5B
  • $100M - 500M
View ProfileView
Nuevolution's top 15 competitors are Bavarian Nordic, Symphogen, Genmab, MorphoSys, IOmet Pharma, Juno Therapeutics, NexImmune, Aura, Janssen, Sutro Biopharma, Medigene, Perthera, bluebird bio, Jounce and CR Pharmaceutical. Together they have raised over 6.0B between their estimated 120.0K employees. Nuevolution's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 6.1B. Nuevolution has 43 employees and is ranked 15th among it's top 10 competitors. The top 10 competitors average 7,499.

Nuevolution VS Bavarian Nordic

Bavarian Nordic is perceived as one of Nuevolution's biggest rivals. Bavarian Nordic was founded in 1994, and its headquarters is in Hellerup, Other. Like Nuevolution, Bavarian Nordic also works within the Biotechnology field. Bavarian Nordic has 1,566 more employees than Nuevolution.

Nuevolution VS Symphogen

Symphogen is one of Nuevolution's top rivals. Symphogen is a Private company that was founded in 2000 in Ballerup, Other. Like Nuevolution, Symphogen also competes in the Biotechnology sector. Compared to Nuevolution, Symphogen has 65 more employees.

Nuevolution VS Genmab

Genmab is Nuevolution's #3 rival. Genmab is a Public company that was founded in Copenhagen, Capital Region in 1999. Like Nuevolution, Genmab also operates in the Biotechnology sector. Genmab has 2,492 more employees vs. Nuevolution.

Looking for similar companies to Nuevolution?

Similar Companies

Biotechnology companies in Copenhagen

See 62 companies 
Companies in Copenhagen with revenue in $25-100M range

See 69 companies 
Pharmaceuticals & Biotechnology companies in Copenhagen

See 88 companies 
Biotechnology companies in Denmark

See 218 companies 
Companies in Denmark with revenue in $25-100M range

See 359 companies 
Companies in Copenhagen with employees in 25-100 range

See 372 companies 
Pharmaceuticals & Biotechnology companies in Denmark

See 372 companies 
Biotechnology companies with revenue in $25-100M range

See 881 companies 
Companies in Denmark with employees in 25-100 range

See 1,361 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Nuevolution and Nuevolution's Competitors

Today 3:32 AMNasdaq
(RTTNews) - AbbVie (ABBV) and Genmab A/S (GMAB) released results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a subcutaneously adminis...
January 16, 2026Seeking Alpha
Today 12:37 PMLife Care News
Basel, January 16, 2026 - Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ianal...
January 16, 2026FiercePharma
Just days after AbbVie unveiled a major new oncology play in the form of its high-dollar RemeGen collab, the Illinois drugmaker closed out the week wit...
Today 12:32 AM985theriver
Jan 16 (Reuters) - Danish drugmaker Genmab and its U.S. partner AbbVie said on Friday that their drug for a type of blood cancer failed ‍to improve the...
January 16, 2026centralcharts
Company Announcement Based on the topline results from the EPCORE ® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss next ste...
January 15, 2026Marketscreener
Jyske Bank raises its target price for Genmab to 2,300 Danish kroner (previously 2,000), reiterates its hold recommendation - BN...
Today 11:43 AMNashvillenewsupdates
DelveInsight's "Metastatic Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Meta...
January 15, 2026Bloomberg Law
A federal appeals court panel on Thursday heard Novartis AG's renewed arguments seeking a preliminary injunction against a Missouri law that requires i...

Frequently Asked Questions about Nuevolution

  1. Who are Nuevolution's top competitors?

    Nuevolution's top 3 competitors are Bavarian Nordic, Symphogen, Genmab.

  2. Who is similar to Nuevolution?

    Bavarian Nordic is the most similar to Nuevolution. Symphogen and Genmab are also similar to Nuevolution.

  1. Are Nuevolution and Bavarian Nordic competitors?

    Yes, Bavarian Nordic is one of Nuevolution’s top competitors.